C Radcliffe, M Malinis, MM Azar - Clinics in Chest …, 2023 - chestmed.theclinics.com
… Molnupiravir Ribonucleoside analog of N-hydroxycytidine whose active form interferes with RNA-… Although remdesivir resistance mutations have been reported in immunocompromised …
V Kauer, D Totschnig, M Augustin, M Karolyi, A Zoufaly… - 2023 - europepmc.org
… treated at the outpatient clinic, of whom 420 were treated with SOT, 398 with N/R and 1788 with MOL. 10 patients (3.2%) who were treated … in a population of participants at high risk for …
MVO Len - Revista Española de Quimioterapia, 2023 - ncbi.nlm.nih.gov
… to severe disease, treatment with molnupiravir was associated … on the use of molnupiravir in immunosuppressed patients, as … subgroup of immunosuppressed patients, molnupiravir was …
S Kaore, S Atal - Current Drug Research Reviews Formerly …, 2022 - ingentaconnect.com
… hamsters, mice, immunodeficient mice implanted with human … ) seen in the three molnupiravir treated groups. A significant … evaluation, 10 participants were given molnupiravir 200 mg …
N Jakharia, AK Subramanian, AE Shapiro - Infectious Disease Clinics of …, 2022 - Elsevier
… the different treatment options for immunocompromised … In the MOVe-OUT trial, molnupiravir reduced the rate of … detected in immunocompetent control participants. Factors associated …
DJ Smith - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
… second-line therapy (molnupiravir) reduces the prevalence of … , such as those who are immunocompromised (14). Two … /ritonavir treatment among immunocompromised subjects ¶¶ and …
H Kaduszkiewicz, MM Kochen, S Kluge… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
… Immunosuppressed patients with COVID-19 whose … appropriate treatment options are available, molnupiravir may be … Study participants presented with risk factors for severe COVID-…
K Cowman, A Miller, Y Guo, MH Chang… - Journal of …, 2023 - academic.oup.com
… Participants … period based on characteristics such as immunosuppression, we categorized vaccination as … Of note, the molnupiravir-treated patients in our study had a higher number of …
SA Alpizar, J Accini, DC Anderson, B Eysa… - Journal of Infection, 2023 - Elsevier
… The MITT population comprised 763 participants randomized to molnupiravir and 764 to placebo; 83.6% had anti-… Of note, treatment of COVID-19 with molnupiravir was prohibited in trial …